BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15967826)

  • 41. Human cytomegalovirus specific CD8(+) T lymphocytes display interferon-gamma secretion impairment in kidney transplant recipients with pp65 antigenemia.
    Yang R; Xia T; Xu G; Li Z; Ying Z; Xu X
    Transplant Proc; 2008 Dec; 40(10):3500-4. PubMed ID: 19100424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.
    McLaughlin-Taylor E; Pande H; Forman SJ; Tanamachi B; Li CR; Zaia JA; Greenberg PD; Riddell SR
    J Med Virol; 1994 May; 43(1):103-10. PubMed ID: 8083644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.
    Kern F; Surel IP; Faulhaber N; Frömmel C; Schneider-Mergener J; Schönemann C; Reinke P; Volk HD
    J Virol; 1999 Oct; 73(10):8179-84. PubMed ID: 10482568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation.
    Nebbia G; Mattes FM; Smith C; Hainsworth E; Kopycinski J; Burroughs A; Griffiths PD; Klenerman P; Emery VC
    Am J Transplant; 2008 Dec; 8(12):2590-9. PubMed ID: 18853954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.
    Lim JB; Kim HO; Jeong SH; Ha JE; Jang S; Lee SG; Lee K; Stroncek D
    J Transl Med; 2009 Aug; 7():72. PubMed ID: 19698161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.
    Gratama JW; van Esser JW; Lamers CH; Tournay C; Löwenberg B; Bolhuis RL; Cornelissen JJ
    Blood; 2001 Sep; 98(5):1358-64. PubMed ID: 11520783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.
    Nguyen TH; Sullivan LC; Kotsimbos TC; Schwarer AP; Mifsud NA
    Immunol Cell Biol; 2010 Aug; 88(6):676-84. PubMed ID: 20195281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.
    Jagannathan P; Osborne CM; Royce C; Manion MM; Tilton JC; Li L; Fischer S; Hallahan CW; Metcalf JA; McLaughlin M; Pipeling M; McDyer JF; Manley TJ; Meier JL; Altman JD; Hertel L; Davey RT; Connors M; Migueles SA
    J Virol; 2009 Mar; 83(6):2728-42. PubMed ID: 19129459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.
    Retière C; Prod'homme V; Imbert-Marcille BM; Bonneville M; Vié H; Hallet MM
    J Virol; 2000 May; 74(9):3948-52. PubMed ID: 10756006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.
    Stone SF; Price P; French MA
    J Antimicrob Chemother; 2006 Apr; 57(4):585-8. PubMed ID: 16504998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults.
    Riddell NE; Griffiths SJ; Rivino L; King DC; Teo GH; Henson SM; Cantisan S; Solana R; Kemeny DM; MacAry PA; Larbi A; Akbar AN
    Immunology; 2015 Apr; 144(4):549-60. PubMed ID: 25314332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
    BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical factors influencing phenotype of HCMV-specific CD8+ T cells and HCMV-induced interferon-gamma production after allogeneic stem cells transplantation.
    Gayoso I; Cantisán S; Cerrato C; Sánchez-García J; Martin C; Solana R; Torres-Gomez A; Torre-Cisneros J
    Clin Dev Immunol; 2013; 2013():347213. PubMed ID: 23424600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S; Gentilini C; Hilbers U; Lange T; Rieger K; Hofmann J; Maier M; Liebert UG; Niederwieser D; Engelmann E; Heilbronn R; Thiel E; Uharek L
    Bone Marrow Transplant; 2007 Mar; 39(5):293-9. PubMed ID: 17262060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus.
    Day EK; Carmichael AJ; ten Berge IJ; Waller EC; Sissons JG; Wills MR
    J Immunol; 2007 Sep; 179(5):3203-13. PubMed ID: 17709536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children.
    Bekker V; Bronke C; Scherpbier HJ; Weel JF; Jurriaans S; Wertheim-van Dillen PM; van Leth F; Lange JM; Tesselaar K; van Baarle D; Kuijpers TW
    AIDS; 2005 Jul; 19(10):1025-34. PubMed ID: 15958833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.